# Alpine Immune Sciences Inc. (ALPN)

Source: https://www.quantisnow.com/company/ALPN
Generated: 2026-11-16T04:40:59.793Z

- Ticker: ALPN
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2015
- Website: alpineimmunesciences.com

## About

Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated autoimmune/inflammatory diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the research, development, and commercialization of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.

## Latest ALPN news and filings

- 2025-01-09 13:00 UTC [Leadership Update] [Frazier Life Sciences Appoints Biotech Innovators Mitchell H. Gold and Stanford L. Peng as Venture Partners](https://www.quantisnow.com/insight/frazier-life-sciences-appoints-biotech-innovators-mitchell-h-gold-and-5840481)
- 2024-07-09 11:30 UTC [Public Offering] [Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors](https://www.quantisnow.com/insight/attovia-therapeutics-announces-election-of-mitchell-gold-and-angie-you-5598515)
- 2024-05-30 13:12 UTC [SEC Form 15-12G filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-alpine-immune-sciences-inc-5525270)
- 2024-05-24 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-alpine-immune-sciences-inc-5515167)
- 2024-05-24 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-alpine-immune-sciences-inc-5515153)
- 2024-05-21 20:49 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Alpine Immune Sciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-alpine-immune-sciences-inc-5507966)
- 2024-05-21 14:21 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Alpine Immune Sciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-alpine-immune-sciences-inc-5506596)
- 2024-05-21 00:14 UTC [SEC Form 4] [Peetz Christopher returned 1,900 shares to the company (SEC Form 4)](https://www.quantisnow.com/insight/peetz-christopher-returned-1900-shares-to-the-company-sec-form-5505356)
- 2024-05-21 00:13 UTC [SEC Form 4] [SEC Form 4 filed by Hernday Natasha](https://www.quantisnow.com/insight/sec-form-4-filed-by-hernday-natasha-5505354)
- 2024-05-21 00:12 UTC [SEC Form 4] [SEC Form 4 filed by Drappa Jorn](https://www.quantisnow.com/insight/sec-form-4-filed-by-drappa-jorn-5505353)
- 2024-05-21 00:11 UTC [SEC Form 4] [Conway Robert E returned 50,000 shares to the company (SEC Form 4)](https://www.quantisnow.com/insight/conway-robert-e-returned-50000-shares-to-the-company-sec-5505351)
- 2024-05-21 00:10 UTC [SEC Form 4] [SEC Form 4 filed by Topper James N](https://www.quantisnow.com/insight/sec-form-4-filed-by-topper-james-n-5505350)
- 2024-05-21 00:09 UTC [SEC Form 4] [SEC Form 4 filed by Thompson Peter A.](https://www.quantisnow.com/insight/sec-form-4-filed-by-thompson-peter-a-5505348)
- 2024-05-21 00:08 UTC [SEC Form 4] [SEC Form 4 filed by Cui Xiangmin](https://www.quantisnow.com/insight/sec-form-4-filed-by-cui-xiangmin-5505347)
- 2024-05-21 00:07 UTC [SEC Form 4] [Rickey James Paul returned 57,961 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/rickey-james-paul-returned-57961-shares-to-the-company-closing-5505343)
- 2024-05-21 00:05 UTC [SEC Form 4] [Peng Stanford L returned 344,163 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/peng-stanford-l-returned-344163-shares-to-the-company-closing-5505339)
- 2024-05-21 00:04 UTC [SEC Form 4] [Gold Mitchell returned 109,245 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/gold-mitchell-returned-109245-shares-to-the-company-closing-all-5505334)
- 2024-05-21 00:03 UTC [SEC Form 4] [Fuhs Ulrich Martin returned 30,120 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/fuhs-ulrich-martin-returned-30120-shares-to-the-company-closing-5505332)
- 2024-05-21 00:02 UTC [SEC Form 4] [Durand Remy returned 133,392 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/durand-remy-returned-133392-shares-to-the-company-closing-all-5505324)
- 2024-05-20 23:47 UTC [SEC Form 4] [SEC Form 4 filed by Orbimed Advisors Llc](https://www.quantisnow.com/insight/sec-form-4-filed-by-orbimed-advisors-llc-5505312)
- 2024-05-20 13:37 UTC [SEC Form 25-NSE filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-alpine-immune-sciences-inc-5503199)
- 2024-05-20 12:53 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alpine-immune-sciences-inc-5503051)
- 2024-05-20 12:52 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alpine-immune-sciences-inc-5503049)
- 2024-05-20 12:51 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alpine-immune-sciences-inc-5503045)
- 2024-05-20 12:50 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alpine-immune-sciences-inc-5503043)
- 2024-05-20 12:50 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alpine-immune-sciences-inc-5503038)
- 2024-05-20 12:49 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alpine-immune-sciences-inc-5503035)
- 2024-05-20 12:49 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alpine-immune-sciences-inc-5503034)
- 2024-05-20 12:48 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alpine-immune-sciences-inc-5503022)
- 2024-05-20 12:47 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alpine-immune-sciences-inc-5503018)
- 2024-05-20 12:47 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alpine-immune-sciences-inc-5503017)
- 2024-05-20 12:46 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alpine-immune-sciences-inc-5503014)
- 2024-05-20 12:45 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alpine-immune-sciences-inc-5503010)
- 2024-05-20 12:45 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alpine-immune-sciences-inc-5503006)
- 2024-05-20 12:44 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alpine-immune-sciences-inc-5503005)
- 2024-05-20 12:43 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alpine-immune-sciences-inc-5502999)
- 2024-05-20 12:43 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alpine-immune-sciences-inc-5502998)
- 2024-05-20 12:42 UTC [SEC Form POS AM filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-alpine-immune-sciences-inc-5502989)
- 2024-05-20 12:41 UTC [SEC Form POS AM filed by Alpine Immune Sciences Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-alpine-immune-sciences-inc-5502983)
- 2024-05-20 12:38 UTC [SEC Form 8-K] [Alpine Immune Sciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Completion of Acquisition or Disposition of Assets, Leadership Update](https://www.quantisnow.com/insight/alpine-immune-sciences-inc-filed-sec-form-8-k-notice-of-5502962)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ALPN
- Earnings history: https://www.quantisnow.com/earnings/ALPN
- Dividend history: https://www.quantisnow.com/dividends/ALPN
- Insider transactions: https://www.quantisnow.com/insiders/ALPN
- Options chain: https://www.quantisnow.com/options/ALPN
- SEC 8-K filings only: https://www.quantisnow.com/company/ALPN/8-k
- RSS and alerts for ALPN: https://www.quantisnow.com/docs/rss-feeds.md
